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Abstract: This study was designed to determine the gastroprotective effect of a Mangifera 
indica leaf decoction (AD), on different experimental models in rodents. The 
administration of AD up to a dose of 5 g/kg (p.o.) did not produce any signs or symptoms 
of toxicity in the treated animals, while significantly decreasing the severity of gastric 
damage induced by several gastroprotective models. Oral pre-treatment with AD (250, 500 
or 1000 mg/kg) in mice and rats with gastric lesions induced by HCl/ethanol, absolute 
ethanol, non-steroidal anti-inflammatory drug (NSAID) or stress-induced gastric lesions 
resulted in a significant decrease of said lesions. Phytochemical analyses of AD composition 
demonstrated the presence of bioactive phenolic compounds that represent 57.3% of total 
phenolic content in this extract. Two main phenolic compounds were isolated, specifically 
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mangiferin (C-glucopyranoside of 1,3,6,7-tetrahydroxyxanthone) and C-glucosyl-
benzophenone (3-C-β-D-glucopyranosyl-4’,2,4,6-tetrahydroxybenzophenone). These 
findings indicate the potential gastroprotective properties of aqueous decoction from M. 
indica leaves.  





Acid related disorders are common conditions in the general population. Furthermore, clinical 
experience has shown that acid-related symptoms as well as duodenal ulcers return quickly after 
cessation of drug treatments, raising the possibility of rebound hypersecretion [1]. Therapy in the 
future will continue to focus on control of acid secretion and subsequent reversal of mucosal damage 
and inflammation [2].  
Mangifera indica L. (Anacardiaceae) is one of the most important tropical plants marketed in the 
world [3]. It is a large tree that grows in tropical and subtropical regions, whose fruits are widely 
appreciated by the population. There are many traditional medicinal uses for the bark, roots and leaves 
of M. indica throughout the globe [3]. This plant was listed in TRAMIL (Program of Applied Research 
to Popular Medicine in the Caribbean) as an agent for the treatment of diarrhea, fever, gastritis and 
ulcers [4, 5]. Phytochemical research from different parts of M. indica has demonstrated the presence 
of phenolic constituents, triterpenes, flavonoids, phytosterols, and polyphenols [6-10]. This species is 
purported to posses numerous therapeutic uses including analgesic, anti-inflammatory [11], 
immunostimulant [12-14], antioxidant [15-17], spasmolytic, antidiarrhea [18], dyslipidemic [19], 
antidiabetic [20,21], antiamebic [22], anthelminthic, antiallergic [23] and antibacterial applications 
[24]. Moreover, a previous work carried out by our group showed antiulcerogenic and healing effects 
of aqueous decoction of M. indica flowers [25]. However, the great demand for this decoction has 
diminished the availability of M. indica fruits that are widely appreciated by the population as food. 
Therefore, the study aimed to evaluate the antiulcer activity of the aqueous decoction (AD) obtained 
from the leaves of Mangifera indica using different in vivo experimental models in rodents followed 
by its phytochemical investigation. 
 
Results and Discussion 
 
The gastroprotective action exerted by an aqueous decoction (AD) of Mangifera indica leaves 
emerged from an ethnobotanical inventory from the Traditional Medicine of the Islands (TRAMIL 
project) for development of the Caribbean Medicinal Plant Pharmacopoeia. As part of this 
pharmacological study, the AD obtained from leaves of M. indica was first investigated in relation to 
its acute toxicity in vivo. This application suggests that there would be no toxic effects from the 
administration of this decoction. A single oral administration of AD from M. indica via the oral route 
at dose of 5 mg/Kg did not produce any signs or symptoms of toxicity in the treated animals. During 
the following 14 days after the administration of AD, no animals died and there were no significant 




alteration in water or food consumption. At autopsy, no significant change or lesion was observed in 
the viscera of any animal (Table 1). Loomis and Hayes [26] described the classification of some 
chemical agents into categories of toxicity in which the dose of 5 g/Kg was categorized as practically 
nontoxic, a result which indicates that this preparation from M. indica has no acute toxicological effect 
when administered orally. These results demonstrated the need for continuation of pharmacological 
studies on the oral administration of this decoction and motivated us to continue with the assays. 
 
Table 1. Evaluation of the acute toxicity of aqueous decoction (AD) of M. indica leaves (5 
g/Kg, p.o.) in male Swiss mice (n=10). 
Weight (g) Control AD 
Corporal 43.00 ± 0.63 43.00 ± 1.18 
Kidney 0.59 ± 0.31 0.52 ± 0.02 
Liver 2.00 ± 0.72 1.82 ± 0.09 
Heart 0,23 ± 0.01 0.18 ± 0.02 
Lungs 0.26 ± 0.02 0.23 ± 0.01 
Mortality 0/10 0/10 
Results are mean ± S.E.M; n=10. Student’s t test.  
Not significant p>0.05. 
Intragastric application of absolute ethanol has long been used as a reproducible method to induce 
gastric lesions in experimental animals [27]. Recent studies have demonstrated that ROS (reactive 
oxygen species) such as superoxide anion radical, hydroxyl radical (OH) and lipid peroxidation play 
an important role in pathogenesis of acute gastric damage induced by ethanol [28]. ROS provoke 
severe changes at the cellular level leading to cell death because of their extreme reactivity [29]. The 
oral administration of AD before the induction of gastric lesion by absolute ethanol significantly 
decreased the gastric lesions relative to the control group in which 500 mg/Kg generated 55% of 
inhibition, while 1,000 mg/Kg produced 95% of inhibition (Figure 1). The gastric injury caused by 
ethanol plus hydrochloric acid also can be seen in Figure 1. The pretreatment with AD (at doses of 500 
or 1,000 mg/Kg) before HCl/ethanol solution significantly (p  0.05) decreased the severity of lesions by 
47 and 70%, respectively. These agents confer a direct topical effect on gastric mucosa, which is an 
undesirable sequela and a suitable model to investigate products with possible cytoprotective activity 
[30]. When the gastric mucosal defense is compromised by exogenous agents such as ethanol, these 
compounds penetrate into gastric mucosa and damage the mucosal microvessels [31]. The AD was 
able to reduce stress-induced ulcers diminishing the lesions in relation to the control group at all AD 
doses (250, 500 and 1,000 mg/Kg). Stress causes sympathetic stimulation of the stomach which induces 
direct arteriolar vasoconstriction and gradually reduces the blood flow to the stomach, leading to local 
hypoxia and ischemia [32]. Ischemia increases the leakage of O2 from the mitochondrial electron transport 
chain [33] and facilitates the availability of “redox-active” copper and iron. This leakage of O2 can cause 
lipid peroxidation and lead to a loss of membrane fluidity, impairment of both ion transport and membrane 




integrity, and a loss of cellular functions [34]. These two factors play a joint role in gastric ulcers induced 
by stress.  
 
Figure 1. Effects of different doses of aqueous decoction (AD) of Mangifera indica leaves 











Results are mean ± S.E.M.: Ethanol: F(4;20)= 7.05, HCl/ethanol: F(4; 27) = 6.95;  
NSAID: F(4; 33) = 7.23 and Stress: F(4;28) = 7.54. Dunnett’s test * p<0.05. 
 
NSAIDs are the most widely used pharmacological agents in the treatment of pain, inflammation 
and fever. However 15-30% of patients taking NSAIDs develop peptic ulcers [35]. It is well known 
that prostaglandins (PGs) play a key role in protecting the gastric mucosa against injury caused by a 
variety of necrotizing agents [36]. Under the NSAID model, AD showed significant (p  0.05) activity 
at doses of 250 (61%) and 500 mg/Kg (75%), 1,000 mg/Kg (82%) in relation to vehicle-treated 
animals. This drop in the severity of lesions by augmentation of AD doses demonstrated an important 
difference between aqueous decoction of M. indica obtained from flowers and leaves. Lima et al. [25] 
concluded that the absence of gastroprotective activity at the highest dose of AD obtained from 
flowers probably was due to the chemical compounds in this preparation which induced modulation of 
endogenous prostaglandins.  
The aqueous decoction from Mangifera indica leaves presents a different phytochemical profile 
from the flowers. The phytochemical study of AD of leaves leads to isolation of two phenolic 
compounds, Mi1 and Mi2. Compound Mi1 was obtained as an amorphous yellow solid. The 13C-NMR 
spectrum of compound Mi1 was in complete agreement with the one reported for mangiferin (Figure 
2), a C-glucopyranoside of 1,3,6,7-tetrahydroxyxanthone [37], occurring in a variety of plants. The 
compound Mi2 was identified by spectral analysis as 3-C--D-glucopyranosyl-4’,2,4,6-
tetrahydroxybenzophenone (Figure 3), a C-glucosylbenzophenone. 
















































The HPLC-PDA chromatogram of AD showed the presence of two intense peaks at 254 nm with 
retention times of 11.6 and 40.5 min, respectively (Figure 4). The UV spectra of these peaks, together 
with the analysis of retention time of standard compounds, indicated the isolated Mi2 and Mi1, 
respectively. The total phenolic content obtained in AD from leaves was greater than the percentage 
(57.3%) present in AD of M. indica flowers [25]. 
 
Figure 4. HPLC-UV-PDA fingerprint of the AD of Mangifera indica leaves 1: 



















Many experiments have also demonstrated the role of antioxidants in preventing various human 
diseases by preventing oxidative stress and damage in biological tissues [38]. Due to the presence of 
conjugated ring structures and hydroxyl groups, most phenolic compounds have the potential to 
function as antioxidants by scavenging the superoxide anion, hydroxyl radical and peroxy radical or 
quenching singlet oxygen, thus inhibiting lipid peroxidation in biological systems. M. indica represents 







1 0 20 3 0 4 0 5 0 6 0 m in u tes





















Mangiferin (2--D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one), is a xanthone 
commonly found in various parts of M. indica and has attracted considerable interest in view of its 
numerous therapeutic effects including, for example, antitumor [41], antiviral [42], antidiabetic [43], 
anti-inflammatory [44] and potent antioxidant [17,45,46] properties. A close association between the 
antioxidant activity and antiulcerogenic effect has also been also reported in many studies [38]. One 
recent work described the antiulcerogenic activity of mangiferin against gastric damage induced by 
ethanol and indomethacin [47]. This polyphenol is capable of acting as an antioxidant through many 
mechanisms available in vitro: primarily as potent scavenger of free radicals [48]; as modulating the 
activation and functionality of rat macrophages, through partial inhibition of ROS and RNS production 
[13] and by its ability to bind to iron-complex ions (Fe2+/3+), resulting in membrane lipid peroxidation 
protection [49]. The catechol moiety with a 6,7-dihydroxylated structure, together with its aromatic 
bonds, has been proposed as being responsible for its antioxidant property [45]. During protection 
afforded against free radical production, the catechols are oxidized, generating products including 
semiquinone radicals and quinones. 
Another important class of compounds found in the AD were benzophenones, obtained from natural 
products or by synthetic transformations [50]. This group displays many biological activities including 
antioxidant, anti-inflammatory [51], antitumor [52] and antimicrobial properties [53,54]. In addition, 
some studies have shown the activity of benzophenones against H. pylori [55,56], contributing to the 
healing effects of AD from M. indica.  
 
Conclusions 
In the present work, the aqueous decoction from leaves of Mangifera indica did not show acute 
toxicity but exhibited gastroprotective effects against several ulcerogenic agents. We also 
demonstrated that in this decoction of M. indica leaves the main bioactive molecules are xanthones 





Structures of compounds were determined by combining the 1H-, 13C, and 2D-NMR techniques and 
by comparing their spectroscopic data with those reported in the literature [37]. NMR spectra in 
DMSO-d6 were obtained using a Varian INOVA 500 spectrometer, operating at 11.7 T. Chemical 
shifts are given as δ (ppm) using TMS as internal standard. Mass spectra were registered with a Termo 
Finnigan LCQ Deca ion-trap and Excalibur software. The sample was prepared in MeOH and analyzed 
in negative ion mode (capillary -4V, spray 5kV, lent offset 0V, capillary temperature 280º C, dry gas 
nitrogen at flow a rate of 50, scan 230-1800, injection time 50 ms, 3 microscans, collision energy 
25%). The scan range was m/z 80-2.000. Analytical TLC was performed on Kieselgel 60 F254 
(Merck) plates with 0.2 mm layer thickness. Spots were visualized by UV light or by spraying with 
anisaldheyde/H2SO4 solution after heading. Column chromatography (CC) was performed by gel 
permeation chromatography using a Sephadex LH-20 column (Pharmacia) and silicagel 60 (Merck). 
Compounds were purified using a semipreparative HPLC Knauer Chance system equipped with a 




Waters R401 refractive index detector, a Phenomenex Luna column (RP 18, 10 μm, 250 × 10 mm) and 
a Rheodyne injector with a 100 μL sample loop). All solvents for chromatographic separation were of 
analytical grade, from Synthlab. The chemicals and solutions used were all of analytical grade. All 
drugs and reagents were prepared immediately before use. The following substances and drugs were 
used: absolute ethanol, hydrochloric acid, acetic acid (Sinth, Brazil), cimetidine (Sigma, U.S.A), 
lansoprazole and piroxicam (Hexal, Brazil). 
 
Plant material, extraction and isolation 
 
Leaves of M. indica were collected in Finca San José, Mazatenango, Suchitepéquez (Guatemala). 
Samples of the leaves were identified by the staff of Armando Cáceres and a voucher specimen is kept 
at the Herbarium of Farmaya Laboratory, Guatemala, under the number 810. For this study, Mangifera 
indica leaves were employed in decoction form obtained as follows: The powdered plant (300 g) was 
extracted with water (500 mL), boiled for 30 min. The mixture was filtered with Whatman number 1 
filter paper, cooled and filtered a second time. The filtrate (AD) was lyophilized with a dry-drug yield 
of 13.05%. This extract was stored in a refrigerator at 10 ºC until used and dissolved in distilled water 
on the day of the experiment to prepare the stock solution and different dilutions for the purpose of 
pharmacological or chemical evaluation.  
The AD (2.0 g) was subjected to chromatography over gel permeation (10 x 2.5 cm i.d.) using 
MeOH as eluent. Fractions (5 mL) were collected and checked by TLC on silica-gel plates, mobile 
phase CHCl3/MeOH/n-PrOH/H2O (5:6:1:4, v/v, organic phase). The eluents were combined according 
to TLC control. Fraction 9 was sequentially purified by CC on silica gel (60 H, Merck) column (10 x 5 
cm i.d.) and eluted using solvent mixtures composed of CHCl3/MeOH. The 80 % MeOH fraction 
afforded a yellow crystalline powder (15 mg) denominated Mi1. Fraction 5 was further purified using 
a HPLC-IR. Isocratic elution using MeOH/H2O (45:55, v/v) as mobile phase, at flow rate of 1.5 
mL/min, yielded the benzophenone glycoside Mi2 (12 mg).  
 
Quantitative determination of phenolic content in AD 
The global polyphenol content of AD was determined by the Folin-Ciocalteu colorimetric method 
proposed by Singleton and Rossi [57] with some modifications. An aliquot of the extract (0.100 mg) 
was dissolved in MeOH (2 mL), and the extracts were diluted 10-fold with water. Folin–Ciocalteu 
reagent (0.25 mL, 1:1, v/v, Merck) was added to the diluted solutions (0.25 mL) then distilled water 
(2.0 mL) and a 200 g/L solution of Na2CO3 (0.25 mL) were added. After 30 min at room temperature, 
the absorbance was measured at 760 nm (Hach Dr-4000U spectrophotometer) with a blank sample 
(water plus reagents) in the reference cell. Quantification was expressed by reporting the absorbance in 









Chemical fingerprint of AD 
The chromatographic profile of AD was performed using a Varian, ProStar HPLC system equipped 
with an RP-18 column (250 mm × 4.6 mm i.d., 5 m, Phenomenex Luna). The mobile phase was 
water (A) and acetonitrile (B) starting with linear gradient elution of 21-30% of B in 30 min, 30-36% 
of B in 50 min and 36–100% in 60 min eluted at a flow-rate of 1.17 mL/min, and the effluent was 
monitored using a ProStar 330 photodiode-array ultraviolet detection (PDA) system. Spectral data 
from all peaks were registered in the range 200–400 nm. An aliquot (5.0 mg) of AD was dissolved in 
ultra-pure water and filtered with a 0.22 m membrane (Millipore) to an appropriate solution of 1.0 
mg/mL. The injection volume for samples was 20 L onto the HPLC column.  
 
Spectral data of compounds 
Mi1: Yellow crystalline solid; mp 271 ºC; IR (KBr) νmax: 3.400 (OH), 1.645 (C=O) cm
-1; UV (MeOH) 
λmax 240, 259, 316, 365 nm. EI-MS m/z: 423 [M+H]
+; H-NMR (DMSO-d6) δ: 7.36 (1H, s H-8), 6.84 
(1H, s, H-5), 6.36 (1H, s, H4), 4.60 (1H, d, J=9.8 Hz, glc H-1), 3.19-4,04 (sugar prótons); 13C-NMR 
(DMSO-d6) δ: 177.1 (C-9), 162.3 (C-3), 160.2 (C-1), 154.8 (C-6, C4a), 149.5 (C-10a), 142.6 (C-7), 
111.2 (C-8a), 107.7 (C-8), 107.3 (C-2), 102.4 (C-5), 101.1 (C-9a), 93.3 (C-4), 81.8 (C-5’), 79.3 (C-3’), 
73.5 (C-1’), 71.1 (C-2’), 70.7 (C-4’), 62.2 (C-6’).  
 
Mi2: Brown amorphous solid; IR (KBr) νmax: 3.300 (OH), 1.615 (C=O) cm
-1. UV (MeOH) λmax 210, 
294 nm. EI-MS m/z: 407 [M-H]-, 287 [M-H-120]-; 1H-NMR (DMSO-d6) δ: 7.55 (2H, d, J=8.0 Hz, H-
2’, H-6’), 6.77 (2H, d, J=8.0 Hz, H-3’, H-5’), 5.95 (1H, s, H6), 4.59 (1H, d, J=10.0 Hz, glc H-1), 3.19-
3.58 (sugar protons); 13C-NMR (DMSO-d6) δ: 194.6 (C-7), 161.3 (C-4’), 159.1 (C-4), 157.4 (C-3), 
156.8 (C-2), 131.4 (C-2’, C-6’), 130.7 (C-1’), 114.6 (C-3’, C-5’), 106.9 (C-1), 103.6 (C-5), 94.9 (C-6), 
81.0 (C-5’’), 78.3 (C-3’’), 74.6 (C-1’’), 71.9 (C-2’’), 69.6 (C-4’’), 60.5 (C-6’’).  
 
Animals 
Male Swiss albino mice (25-35 g) and male Wistar albino rats (150-250 g) from the Central Animal 
House of the UNESP were used. The animals were fed a certified Nuvilab (Nuvital) diet with free 
access to tap water under standard conditions of 12 h dark-12 h light, humidity (60  1.0%) and 
temperature (21  1%). Fasting was used prior to all assays because standard drugs and infusion were 
always administered orally (by gavage) or intraduodenally using a saline solution (10 mL/Kg) as the 
vehicle. Moreover, the animals were kept in cages with raised floors of wide mesh to prevent 
coprophagy. The number of animal was enough the statistical analysis and we reduced number of 
animals to respect the Ethical Animal Care. The animals were killed by CO2 gas (1 min with outflow 
15 L/min) and all experiments following the recommendations of the Canadian Council on Animal 
Care [58] and all of the employed protocols were approved by UNESP Institutional Animal Care and 
Use Committee.  
 
 




Acute toxicity  
The acute toxicity studies of M. indica were performed in mice. In this assay, increasing doses of 
AD were orally administered to groups of ten animals for each dose after a 12 h fast. Animals 
receiving the vehicle (saline) served as control. The signs and symptoms associated with the AD 
administration (5 g/Kg, p.o.) were observed at 0, 30, 60, 120, 180 and 240 min after and then once a 
day for the next 14 days. At the end of the period the number of survivors was recorded. The acute 
toxicological effect was estimated by the method described by Souza Brito [59].  
 
Gastroprotective effect against different ulcerogenic agents: HCl/ethanol-induced ulcer [60] - Mice 
were divided into groups (n=6-7) that had each fasted for 24 h prior to oral dosing with the vehicle (10 
mL/Kg), lansoprazole (30 mg/Kg) and AD (250, 500 or 1,000 mg/Kg). Fifty minutes after the 
treatments, all animals received a 0.3 M HCl/60% EtOH solution (0.2 mL) orally. Animals were killed 
1 h after the administration of HCl/EtOH solution. The stomachs were removed, opened along the 
greater curvature and fixed between two glass plates. Ulcerative lesions were calculated according to 
the methodology described by Szelenyi and Thiemer [61]. Indomethacin-induced gastric ulcers in mice 
according to Rainsford [62] - In this model, gastric lesions were induced with indomethacin (30 
mg/Kg, s.c.) and administered to mice (n=7-8) after a 24 h fast. The AD (250, 500 or 1,000 mg/Kg), 
cimetidine (100 mg/Kg) or vehicle was administered orally 30 min before the induction of gastric 
ulcer. The animals were killed 4 h after treatment with the ulcerogenic agent. The stomachs were 
removed and ulcerative lesions were calculated as described previously. Absolute-Ethanol-induced 
damage [30] - After a total of 24 h fasting, five groups of rats (n=5) received an oral administration of 
AD (250, 500 or 1,000 mg/Kg), lansoprazole (30 mg/Kg) or vehicle (10 mL/Kg). One hour after 
treatment, all rats received one mL of 99.5% ethanol to induce gastric ulcer. The animals were killed 
one hour after treatment with the ulcerogenic agent and the stomachs removed to determine the lesion 
damage. Hypothermic Restraint Stress Ulcer [63]. After having fasted for 24 h, mice (n=7-8) received 
an oral administration of AD (250, 500 or 1,000 mg/Kg), cimetidine (100 mg/Kg) or vehicle (10 
mL/Kg). One hour after treatment, mice were immobilized in a restraint cage at 4C for 4 h to induce 
gastric ulcer. The animals were killed and the stomachs removed and opened along the greater 
curvature to determine the number of gastric lesions. The differences between the times of oral 
administration of AD are in accordance to animal species and metabolisms and all methods are in 
accordance to authors that standardized each one.  
 
Statistical analysis  
Results are expressed as mean ± S.E.M. Statistical significance was determined by one-way analysis of 
variance followed by Dunnett’s or Student’s test, with the level of significance at p < 0.05. 
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